Related Experiment Video

Updated: Jun 24, 2025

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.1K

Targeted inhibition of SUMOylation: treatment of tumors

Hongwei Zhao1, Panpan Zhao1, Chao Huang2

  • 1School of Basic Medical Sciences, Department of Medicine, Kunming University of Science and Technology, Kunming, China.

Human Cell
|June 10, 2024
PubMed

Insights

SUMOylation, a protein modification, drives tumor growth and drug resistance. Inhibiting SUMOylation offers a promising therapeutic strategy for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • SUMOylation is a reversible post-translational modification (PTM) crucial for regulating cellular processes.
  • Aberrant SUMOylation in cancer cells promotes proliferation, metastasis, immune evasion, and drug resistance.

Purpose of the Study:

  • To review the SUMOylation cycle pathway.
  • To summarize the role of SUMOylation in tumor initiation and progression.
  • To explore SUMOylation inhibitors as a potential cancer therapeutic strategy.

Main Methods:

  • Literature review of SUMOylation pathways and cancer biology.
  • Analysis of SUMOylation's role in tumor development.
  • Evaluation of SUMOylation inhibitors' efficacy in preclinical and clinical settings.

Main Results:

  • Overexpression of SUMOylation components enhances tumor cell survival and progression.
  • Blocking SUMOylation can inhibit tumor initiation and progression.
  • SUMOylation inhibitors show potential in combination cancer therapy.

Conclusions:

  • SUMOylation is a critical regulator in cancer.
  • Targeting SUMOylation presents a viable therapeutic approach for cancer treatment.
  • Further research into SUMOylation inhibitors is warranted for clinical application.
Keywords:
SUMO familySUMO proteasesSUMOylationSUMOylation inhibitorsTumor

More Related Videos

Localization of SUMO-modified Proteins Using Fluorescent Sumo-trapping Proteins06:23

Localization of SUMO-modified Proteins Using Fluorescent Sumo-trapping Proteins

Published on: April 27, 2019

8.5K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

9.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K